Healthcare -
Biotechnology - NASDAQ - US
$ 7.58
-2.57 %
$ 162 M
Market Cap
-1.53
P/E
ENTA - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss ENTA - Enanta Pharmaceuticals, Inc.
302 K
LAST VALUE
44.26%
2 YEAR CAGR
15.65%
5 YEAR CAGR
17.51%
10 YEAR CAGR